Results 101 to 110 of about 142 (121)
Some of the next articles are maybe not open access.
Salvage therapy of complicated Candida albicans spondylodiscitis with Rezafungin
European Journal of Clinical Microbiology & Infectious DiseasesInvasive fungal infections, particularly those caused by Candida species, represent an increasing cause of hospital-related morbidity and mortality. Most commonly Candida spp. is the causative agent of candidemia and invasive candidiasis. In this report we present a complex case of Candida albicans spondylodiscitis, successfully treated with rezafungin,
Grasselli Kmet, Nina +5 more
openaire +3 more sources
Rezafungin (Rezzayo) for Invasive Candida Infections
The Medical Letter on Drugs and TherapeuticsThe FDA has approved rezafungin (Rezzayo – Cidara/Melinta), an intravenous echinocandin antifungal, for once-weekly treatment of candidemia and invasive candidiasis (IC) in adults with limited or no alternative options. It is the first new drug to become available in the US in more than 15 years for treatment of systemic Candida infections.
openaire +2 more sources
Expert Opinion on Pharmacotherapy
Invasive fungal infections, especially candidemia and invasive candidiasis, continue to cause substantial morbidity and mortality. In addition, the emergence of drug-resistant Candida species, notably C. glabrata and C. auris, along with limitations in available treatments, highlights the urgent need for novel, effective antifungal agents.This review ...
Divisha, Sharma, Jose A, Vazquez
openaire +2 more sources
Invasive fungal infections, especially candidemia and invasive candidiasis, continue to cause substantial morbidity and mortality. In addition, the emergence of drug-resistant Candida species, notably C. glabrata and C. auris, along with limitations in available treatments, highlights the urgent need for novel, effective antifungal agents.This review ...
Divisha, Sharma, Jose A, Vazquez
openaire +2 more sources
Diagnostic Microbiology and Infectious Disease
Severe fungal infection known as invasive candidiasis primarily impacts critically ill alongside immunocompromised patients with high mortality and long hospital stays and creates substantial healthcare expenses. Echinocandins constitute the current standard first-line treatment for invasive candidiasis, with caspofungin being among the most widely ...
Mohammad Al Diab Al Azzawi +8 more
openaire +2 more sources
Severe fungal infection known as invasive candidiasis primarily impacts critically ill alongside immunocompromised patients with high mortality and long hospital stays and creates substantial healthcare expenses. Echinocandins constitute the current standard first-line treatment for invasive candidiasis, with caspofungin being among the most widely ...
Mohammad Al Diab Al Azzawi +8 more
openaire +2 more sources
679: Effect of Moderate Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin
Critical Care Medicine, 2020Voon Ong +6 more
openaire +1 more source